MAPT and Alzheimer disease: While Kaem reduced 62.2% of AT8 (for p-Tau Ser202/Thr205)-positive cells, Rhap abrogated 73.5% of AT8-positive cells in the hippocampus of the 3xTg AD mice (Fig. 6m,n).